What are the most common side effects of Multiple Myeloma treatment
For informational purposes only
This answer was generated by AI grounded in NCCN guidelines and published medical literature. It is not medical advice. Always consult your oncologist or care team before making treatment decisions.
Common Side Effects of Multiple Myeloma Treatment
Multiple myeloma treatment typically involves combinations of medications, and side effects vary depending on which drugs you're receiving. Here's what you should know:
Most Common Side Effects
According to NCCN Guidelines for Multiple Myeloma, the most frequently reported side effects include:
General symptoms:
- Fatigue and weakness (very common)
- Drowsiness
- Headaches
- Chills
- Loss of appetite
- Nausea and vomiting
- Diarrhea or constipation
Blood-related effects:
- Low white blood cell count (increases infection risk)
- Low red blood cell count (causes anemia)
- Low platelet count (increases bruising and bleeding risk)
Nerve and circulation issues:
- Numbness, tingling, or pain in hands/feet (called peripheral neuropathy)
- Blood clots
- Shortness of breath
Other side effects:
- Skin rash
- Muscle aches
- Heart issues (in some cases)
- Common cold or infections
Important Context
Variability matters: Some people experience many side effects while others have very few. The severity also varies—some side effects are minor inconveniences, while others are more serious and require medical attention.
Timing: Most side effects appear soon after treatment starts and go away after treatment ends. However, some can be long-term or appear years later.
Side Effects by Treatment Type
Targeted therapy drugs (proteasome inhibitors, monoclonal antibodies, CAR T-cell therapy) commonly cause the symptoms listed above, plus they can lower mineral and electrolyte levels in your body.
Chemotherapy drugs specifically can cause:
- Mouth sores
- Hair loss
- Bone marrow damage (which is why timing matters for stem cell harvesting if you're having a transplant)
Bone-strengthening medications (bisphosphonates like zoledronic acid or denosumab) can cause:
- Jaw bone problems (osteonecrosis of the jaw) - which is why dental care before treatment is strongly recommended
- Kidney function changes (monitored with blood tests)
What You Should Do
According to NCCN Guidelines, it's essential to:
- Report side effects promptly to your treatment team—don't wait or assume they're normal
- Ask which side effects are most common for YOUR specific drug combination
- Discuss management strategies—many side effects can be treated or reduced
- Know which symptoms need immediate attention (severe bleeding, high fever, chest pain, etc.)
Questions to Ask Your Care Team
- Which side effects are most common with my specific treatment combination?
- How long do these side effects usually last?
- Are there medications or strategies to manage specific side effects?
- What symptoms should I report right away, and who should I contact?
- Do any side effects get better or worse over time?
- Are there any long-term or permanent side effects I should know about?
This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.
This is general information.
Upload your records for guidance specific to YOUR diagnosis — personalized to your biomarkers, stage, and treatment history.
Source Guidelines
NCCN Guidelines for Patients: Multiple Myeloma (2026)Browse all NCCN Guidelines for Patients →Related Services
Services that may help with treatment for Multiple Myeloma patients
Get guidance specific to your case
This answer covers general information. For guidance based on YOUR records, biomarkers, and treatment history:
Related Questions
What is the life expectancy for multiple myeloma cancer
I understand this is one of the most important questions you might have. Let me share what the current medical evidence shows, while being clear about
What is the 5-year survival rate for multiple myeloma
I appreciate this important question, but I need to be transparent with you: the NCCN Guidelines for Patients materials I have access to don't include
What is the average survival rate for multiple myeloma by stage
I appreciate this important question. However, I need to be direct with you: the NCCN Guidelines for Patients that I have access to do not include spe